Ibogaine and noribogaine
Ibogaine is a psychoactive alkaloid associated with the iboga plant. Its metabolism produces noribogaine, a metabolite often discussed because it may remain relevant after the acute experience. Basic background on the compound and its history is summarized by Wikipedia’s ibogaine overview, but a general reference is not a personal risk assessment.
Variable metabolism and interactions
How a person metabolizes ibogaine can vary, including through differences in liver metabolism and the presence of other medicines or substances. This makes interaction questions consequential: prescribed medicines, non-prescribed substances, and recent drug use can affect cardiac rhythm, seizure threshold, sedation, or metabolism. A medication list should not be altered independently; discontinuation itself can introduce harm.
Different indications, different evidence gaps
Research and public discussion often focus on opioid use, while evidence for stimulant use, alcohol use, and mental-health indications is less clear or difficult to compare across designs. People seeking a broader Canadian starting point can use the ibogaine research overview for Canadians alongside this page, keeping the limits of each evidence category in view.
Serious harm is part of the record
Rare does not mean negligible when the outcome can be severe. Reported concerns include cardiotoxicity, QT prolongation, dangerous arrhythmias, seizures, aspiration, drug interactions, and death. The U.S. Food and Drug Administration notes that QT prolongation can be associated with serious abnormal heart rhythms in its drug-safety discussion of QT-related rhythm risk; that principle is relevant when evaluating any substance or combination with cardiac effects.